Neon Therapeutics Company
NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.
Technology:
CAR-T therapy, Cell-based gene therapy, End-to-end Drug Development
Industry:
End-to-end Drug Development, Public
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
101-250
Funding Status:
M&A
Investors Number:
11
Total Funding:
161000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2017-12-05
Last Funding Type:
Series B
Register and Claim Ownership